MODELLING EARLY-TO-LATE STAGE PROGRESSION OF CARDIAC FIBROSIS THROUGH "BIOARTIFICIAL" SCAFFOLDS: AN IN VITRO PLATFORM FOR PRECLINICAL VALIDATION OF NEW THERAPIES IN CARDIAC DISEASE-MICROENVIRONMENTS
TISSUE ENGINEERING PART A（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要